Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial

BACKGROUND: Major Depressive Disorder (MDD) has been associated with brain-related changes. However, biomarkers have yet to be defined that could “accurately” identify antidepressant-responsive patterns and reduce the trial-and-error process in treatment selection. Cerebral blood perfusion, as measu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Crystal M., Chin Fatt, Cherise R., Jha, Manish, Fonzo, Gregory A., Grannemann, Bruce D., Carmody, Thomas, Ali, Aasia, Aslan, Sina, Almeida, Jorge R.C., Deckersbach, Thilo, Fava, Maurizio, Kurian, Benji T., McGrath, Patrick J., McInnis, Melvin, Parsey, Ramin V., Weissman, Myrna, Phillips, Mary L., Lu, Hanzhang, Etkin, Amit, Trivedi, Madhukar H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543260/
https://www.ncbi.nlm.nih.gov/pubmed/31193824
http://dx.doi.org/10.1016/j.eclinm.2019.04.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543260/
https://www.ncbi.nlm.nih.gov/pubmed/31193824
http://dx.doi.org/10.1016/j.eclinm.2019.04.007

Ejemplares similares